Introduction
============

An increasing number of cohort studies have shown that long-term exposure to air pollution is associated with all-cause and cardiovascular mortality ([@r14]; [@r19]; [@r37]; [@r38]). A recent air pollution review completed by the American Heart Association suggested that the inhalation of particulate matter (PM) accelerates or enhances the development of atherosclerosis, and triggers clinical ischemic events ([@r5]).

Increased carotid intima-media thickness (CIMT) is an important indicator of subclinical atherosclerosis and provides a means to assess the development and progression of atherosclerotic vascular disease ([@r24]). The high burden of cardiovascular disease (CVD) and the extraordinarily high mortality rates associated with it indicate that CVD is a major public health concern in several countries. Furthermore, the process of global population aging indicates that this burden is likely to increase, necessitating more proactive CVD prevention strategies. Atherosclerosis begins early in life and progresses throughout the life span. The subclinical atherosclerosis index of CIMT increases with age and in line with age-dependent CVD risk factors ([@r30]). CIMT has been used as an index of subclinical atherosclerosis and CVD in many epidemiological and clinical studies ([@r10]; [@r23]; [@r24]; [@r31], [@r30]).

Several studies examining the association between long-term exposure to air pollution and CIMT have reported inconsistent findings ([@r1]; [@r4]; [@r18], [@r17]; [@r21]; [@r34]). One possible explanation for this inconsistency is the misclassification of individual exposures to air pollution due to the use of fixed-site monitoring data; the usual approach applied was to create a spatial model to describe the space between fixed-site monitors ([@r1]; [@r4]; [@r18], [@r17]; [@r21]; [@r34]), or the distance to major roads to assign individual exposure ([@r1]; [@r17]; [@r21]). A large-scale project conducted by the European Union called the European Study of Cohorts for Air Pollution Effects (ESCAPE) focused on the health effects of long-term exposure to air pollution in existing cohorts, with the aim of improving the estimation of pollution exposure levels of individuals within those cohorts ([@r2]; [@r6]; [@r12], [@r13]; [@r28]).

This project integrated 24 research groups from 15 European countries. The National Taiwan University was the 25th partner to participate in ESCAPE ([@r12]) and is the only ESCAPE partner based outside of Europe. ESCAPE used dedicated exposure assessment campaigns to monitor PM with diameter ≤ 10 μm or ≤ 2.5 μm (PM~10~ and PM~2.5~), and PM~2.5~ absorbance (PM~2.5~abs), nitrogen oxide (NO~2~), and NO~x~ (nitrogen oxides; NO and NO~2~). The study also obtained geographical information about land use in participating cities to develop land-use regression (LUR) models ([@r12], [@r13]) and assigned 1-year exposures to air pollution to the cohort's members. The ESCAPE project has reported significant associations of long-term air pollution effects with acute coronary events, lung cancer, and mortality by harmonizing air pollution exposures on study subjects across European cohorts ([@r2]; [@r6]; [@r28]).

The present study was carried out to evaluate the association between 1-year average exposures to air pollution and CIMT in adults living in the Taipei metropolis of Taiwan.

Methods
=======

*Study subjects.* Between 2009 and 2011, 689 adults 35--65 years of age attended a case--control study of work- and environment-related cardiovascular diseases as the control subjects of acute coronary heart diseases (CHD) in National Taiwan University Hospital ([@r9]). The subjects were volunteers recruited by a bulletin announcement for participating in a case--control study of work- and environment-related cardiovascular diseases in the hospital. Participants reported they were free from physician-diagnosed CHD, cerebrovascular disease, and heart failure. Participants underwent noninvasive cardiovascular examination, including carotid duplex, blood sampling, and a structured questionnaire relating to lifestyle (smoking, alcohol use, and exercise habit), as well as medical history. After a fasting period of 10--14 hr, subjects who were not reported to be diabetic before enrollment underwent a standard oral glucose tolerance test with 75-g glucose loading. A fasting venous blood sample was sent for measurement of fasting blood glucose; lipid profile, including total cholesterol, triglycerides, high- and low-density lipoprotein cholesterol (HDL-C and LDL-C); albumin; renal function; and liver function. The institutional review board of the National Taiwan University Hospital ethics committee approved this study, and all participants gave informed, written consent before recruitment.

*Assessment of CIMT and carotid atherosclerosis.* Carotid atherosclerosis in the common carotid artery (CCA) was assessed by measuring CIMT using a high-resolution B-mode, GE Vivid *i* ultrasound system (GE Healthcare, Horten, Norway) equipped with a 3.5- to 10-MHz real-time B-mode scanner. The measurement protocol for carotid atherosclerosis has been described previously ([@r10]; [@r22]; [@r31], [@r30]). The CIMT measurement was a system-based built-in software in GE Vivid *i* ultrasound system. Maximum and mean CIMT distal to the carotid bifurcation, bulb, and internal carotid artery were measured bilaterally. CCA1 and CCA2 are points located at 0--1 cm and 1--2 cm, respectively, along the CCA, distal to the carotid bifurcation. CIMT of the posterior wall of the distal CCA was measured as the distance from the leading edge of the first echogenic line to the second line. All scans were recorded on a digitalized memory system in Digital Imaging and Communications in Medicine format for subsequent offline analysis. The digitized M-mode was later analyzed offline using a computer program, in which each image was magnified, and the CIMT between two successive R waves was measured by automated analysis software (GE Healthcare).

Because measurements of CIMT taken in the CCA are more strongly associated with cardiovascular risk factors than CIMT in the bulb and internal carotid artery ([@r27]), we chose CIMT in the CCA as our outcome measure for this study. The technician conducted a second reading for 30 randomly selected participants 2 weeks after the first measurement was taken. The reliability of mean and maximum CIMT measurement in the left and right CCA had an excellent intraobserver agreement of 98.8% and 97.6% for LCCA, and 97.8% and 97.3% for RCCA, respectively.

*Assessments of vascular risk factors.* We recruited volunteers to receive cardiovascular health examination in the morning of Wednesday or Saturday during 0830--1200 hours. Subjects who had systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure ≥ 90 mmHg, or were taking antihypertensive medicines, were considered to be hypertensive. Diabetes mellitus (DM) was defined as fasting glucose levels ≥ 126 mg/dL (7.0 mmol/L), a history of DM controlled by medication, or DM diagnosed by the oral glucose tolerance test \[glucose level at 120 min postchallenge ≥ 200 mg/dL (11.1 mmol/L)\]. Hypercholesterolemia was defined as a cholesterol level ≥ 240 mg/dL (6.2 mmol/L) or being treated with lipid-lowering medications. Obesity was defined as body mass index (BMI) ≥ 27 kg/m^2^, according to the Taiwanese definition ([@r26]).

*Exposure to PM~10~, PM~2.5~, PM~2.5~abs, NO~2~, and NO~x~.* Exposure measurements for each subject in Taipei were made according to a verified methodology developed by the ESCAPE project that has been described elsewhere ([@r20]). Briefly, air pollution monitoring campaigns were performed between September 2009 and August 2010 in the study area. Three 2-week measurements of NO~2~ and NO~x~ were performed within 1 year at 40 sites. Simultaneous measurements of PM~10~, PM~2.5~, and PM~2.5~abs (blackness of the PM~2.5~ exposed filter, determined by measurement of light reflectance as a marker for soot and black carbon) were performed at half of the sites. Results from the three measurements were averaged to estimate the annual average concentration of each pollutant. Variables on nearby traffic, population/household density, and land use derived from geographic information systems (GIS) were evaluated as predictors of the spatial variation in annual average concentrations. The traffic representations of Taipei were obtained from a digital map of traffic networks in Taiwan, which was completed by the Institute of Traffic and Transportation in 2010. Population and household data for 2010 were collected from the Household Registration Office of each district in Taipei. The topographic altitude map was obtained from the City Offices. Land use information was taken from the Land Use Investigation of Taiwan conducted by the National Land Surveying and Mapping Center in 2007 (<http://www.nlsc.gov.tw/En/MakePage/166?level=166>). We required a spatial resolution of at least 100 m. Regression models were developed to maximize the adjusted explained variance, using a supervised forward stepwise approach. LUR models were then used to estimate annual average air pollution concentrations at the participants' addresses, for which the same GIS predictor variables were collected. Overall model performance was evaluated by leave-one-out cross-validation: Each site was sequentially left out from the model while the included variables were left unchanged.

*Statistical analysis.* For the basic characteristics of participants, continuous variables are expressed as mean ± SD, and binary variables are presented as number (percent). The 1-year average long-term exposure concentrations for the five air pollutants (PM~2.5~, PM~2.5~abs, PM~10~, NO~2~, and NO~x~) are expressed as mean (± SD), median, and interquartile range. The rationale for choosing covariates in the multivariate analysis was based on prior knowledge of major risk factors for CVD and atherosclerosis, such as hypertensive status (or SBP), hypercholesterolemia (or LDL-C), DM, or obesity. In addition, age, sex, education, ever having smoked, and lipid-lowering treatment are also important factors that may affect atherosclerosis.

Multivariate linear regression analyses were used to assess the association between maximum and mean CIMT at LCCA and RCCA and for both combined (CCA) in association with air pollution exposures. All models were adjusted for age, BMI, SBP, and serum LDL-C concentration as continuous variables; and sex, DM (yes/no), education (≥ or \< 12 years), and ever (vs. never) having smoked as dichotomous variables. Associations with the five pollutants studied were expressed as percentage change \[95% confidence interval (CI)\] in estimated maximum and mean CIMT at CCA per selected unit increase in 1-year average level of each air pollutant, as estimated by LUR models. For comparison, the unit of air pollutants was selected in line with the ESCAPE project.

Interaction analysis was conducted for evaluating whether the covariates are confounders. Subgroup analysis was conducted for evaluating effect modification for air pollution by stratified age, sex, BMI, hypertension, hypercholesterolemia, lipid-lowering treatment, DM, and ever smoking. When the single-pollutant model is significant, we will do two-pollutant model. In this study, we applied PM~2.5~abs as index of particle pollutant and NO~2~ as index of gaseous pollutant to test the interaction effects based on the major findings.

All analyses were performed using SAS software (version 9.1.3; SAS Institute Inc., Cary, NC). A significance level of 0.05 with a two-tailed distribution was considered to be statistically significant.

Results
=======

The basic characteristics and exposure data for the 689 study subjects are listed in [Table 1](#t1){ref-type="table"}. Our study population was composed mainly of males (72%) and middle-aged adults with a mean age of 49 ± 8 and 52 ± 8 years for males and females, respectively. Mean and maximum CIMT of the LCCA were 0.59 ± 0.13 mm and 0.73 ± 0.15 mm for males and 0.57 ± 0.12 mm and 0.72 ± 0.17 mm for females, respectively. The mean and maximum CIMT of the RCCA were 0.58 ± 0.12 mm and 0.72 ± 0.15 mm for males and 0.56 ± 0.10 mm and 0.69 ± 0.11 mm for females, respectively. The study population had low levels of ever smoking (32.9% of males and 1.6% of females had ever smoked), and a minority had \< 12 year formal education (21% of males and 31% of females). The prevalence of DM was 34% for males and 35% for females. The prevalence of hypercholesterolemia was 41% for males and 52% for females in the study population.

###### 

Demographic and clinical characteristics and CIMT in the CCA of participants.

  Variable                                                                                                                                                                                                                                                                                                                        Male (*n* = 497)   Female (*n* = 192)   *p*-Value
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------ -------------------- -----------
  Age (years)                                                                                                                                                                                                                                                                                                                     49 ± 8             52 ± 8               \< 0.001
  BMI (kg/m^2^)                                                                                                                                                                                                                                                                                                                   25.6 ± 3.0         23.6 ± 4.0           \< 0.001
  Systolic blood pressure (mmHg)                                                                                                                                                                                                                                                                                                  125.0 ± 13.9       124.0 ± 15.7         0.42
  Diastolic blood pressure (mmHg)                                                                                                                                                                                                                                                                                                 77.6 ± 9.6         76.4 ± 10.3          0.16
  Hypertension, yes                                                                                                                                                                                                                                                                                                               147 (29.58)        58 (30.21)           0.86
  Cholesterol (mmol/L)                                                                                                                                                                                                                                                                                                            6.0 ± 1.5          6.6 ± 2.0            \< 0.001
  Triglycerides (mmol/L)                                                                                                                                                                                                                                                                                                          2.7 ± 3.1          2.7 ± 3.4            0.79
  Hypercholesterolemia^*a*^, yes                                                                                                                                                                                                                                                                                                  203 (40.8)         99 (51.6)            0.01
  HDL-C (mmol/L)                                                                                                                                                                                                                                                                                                                  1.3 ± 0.4          1.6 ± 0.5            \< 0.001
  LDL-C (mmol/L)                                                                                                                                                                                                                                                                                                                  3.6 ± 1.3          3.7 ± 1.7            0.63
  Fasting blood glucose (mmol/L)                                                                                                                                                                                                                                                                                                  5.5 ± 1.4          5.3 ± 1.1            0.10
  DM^*b*^, yes                                                                                                                                                                                                                                                                                                                    169 (34.0)         68 (35.2)            0.71
  Ever smoking habit, yes                                                                                                                                                                                                                                                                                                         163 (32.8)         3 (1.6)              \< 0.001
  Current smoker                                                                                                                                                                                                                                                                                                                  108 (21.69)        2 (1.04)             \< 0.001
  Education, \< 12 years                                                                                                                                                                                                                                                                                                          106 (21.33)        60 (31.3)            0.006
  Lipid-lowering treatment                                                                                                                                                                                                                                                                                                        51 (10.26)         13 (6.77)            0.16
  CIMT (mm)                                                                                                                                                                                                                                                                                                                                                               
  CCA, mean                                                                                                                                                                                                                                                                                                                       0.58 ± 0.11        0.56 ± 0.10          0.04
  Maximum                                                                                                                                                                                                                                                                                                                         0.73 ± 0.14        0.70 ± 0.12          0.06
  LCCA, mean                                                                                                                                                                                                                                                                                                                      0.59 ± 0.13        0.57 ± 0.12          0.09
  Maximum                                                                                                                                                                                                                                                                                                                         0.73 ± 0.15        0.72 ± 0.17          0.30
  RCCA, mean                                                                                                                                                                                                                                                                                                                      0.58 ± 0.12        0.56 ± 0.10          0.04
  Maximum                                                                                                                                                                                                                                                                                                                         0.72 ± 0.15        0.69 ± 0.11          0.02
  Values are mean ± SD or *n* (%). ^***a***^Cholesterol level ≥ 6.2 mmol/L or being treated with lipid-lowering medications. ^***b***^Fasting glucose levels ≥ 7.0 mmol/L, a history of DM controlled by medication, or DM diagnosed by the oral glucose tolerance test (glucose level at 120 min postchallenge ≥ 11.1 mmol/L).                                           

There were four to six variables, such as the length of major road, road area, urban green area, industrial area, commercial area, and river area, included in the LUR models. The leave-one-out cross-validation *R*^2^ of LUR models used for exposure estimation were 0.91, 0.92, 0.74, 0.63, and 0.81 for PM~2.5~, PM~2.5~abs, PM~10~, NO~2~, and NO~x~, respectively. The root mean square errors of the above air pollutants were 1.51 μg/m^3^, 0.09 × 10^--5^/m, 2.36 μg/m^3^, 6.36 μg/m^3^, and 10.7 μg/m^3^, respectively. LUR estimated 1-year average air pollution levels indicate that our study subjects were exposed to relatively high concentrations of PM~2.5~ (27.34 ± 5.12 μg/m^3^) and PM~10~ (44.21 ± 4.19 μg/m^3^) compared to the air quality goals of the World Health Organization (10 μg/m^3^ for PM~2.5~ and 20 μg/m^3^ for PM~10~) (<http://www.who.int/mediacentre/factsheets/fs313/en/>). In addition, the estimated exposures of PM~2.5~abs, NO~2~, and NO~x~ were 1.97 ± 0.36 (10^--5^/m), 46.13 ± 11.32 μg/m^3^, and 68.37 ± 21.35, respectively ([Table 2](#t2){ref-type="table"}). A correlation analysis found positive correlations between each of the exposures among these five air pollutants for our study subjects, with correlation coefficients ranging from 0.38 to 0.91 (see Supplemental Material, Table S1).

###### 

Estimated 1-year air pollution concentration by land-use regression models.

  Variables                Mean ± SD       Median   Q1      Q3
  ------------------------ --------------- -------- ------- -------
  PM~2.5~ (μg/m^3^)        27.34 ± 5.12    26.98    23.67   30.45
  PM~2.5~abs (10^--5^/m)   1.97 ± 0.36     1.96     1.70    2.23
  PM~10~ (μg/m^3^)         44.21 ± 4.19    43.56    40.93   46.92
  NO~2~ (μg/m^3^)          46.13 ± 11.32   46.53    40.40   53.62
  NO~x~ (μg/m^3^)          68.37 ± 21.35   67.68    57.01   83.45
  Q, quartile.                                              

After adjusting for the *a priori* covariates, maximum CIMT at LCCA was significantly higher in association with average 1-year exposures to PM~10~, PM~2.5~abs, NO~2~, and NO~x~, but not with PM~2.5~ ([Table 3](#t3){ref-type="table"}). The average percentage difference in maximum CIMT at LCCA was 4.23% higher (95% CI: 0.32, 8.13) per 1 × 10^--5^/m PM~2.5~abs, 3.72% higher (95% CI: 0.32, 7.11) per 10 μg/m^3^ PM~10~, 2.81% higher (95% CI: 0.32, 5.31) per 20 μg/m^3^ NO~2~, and 0.74% higher (95% CI: 0.08, 1.41) per 10 μg/m^3^ NO~x~. Mean CIMT at LCCA was significantly higher in association with exposure to PM~10~ and PM~2.5~abs only ([Table 3](#t3){ref-type="table"}). PM~2.5~ mass was not associated with maximum or mean CIMT at LCCA, and none of the air pollutants were associated with maximum or mean CIMT at right CCA. However, in the association between air pollutants and combined CCA estimates, only NO~2~ was evident with maximum CIMT and PM~10~ was significantly with mean CIMT. Both left and right maximum and mean CIMT were significantly associated with established cardiovascular risk factors. For example, maximum and mean LCCA in models that also included PM~2.5~abs were higher in association with LDL-C (1.80% higher, 95% CI: 0.79, 2.81 for a 1-mmol/L increase), SBP (2.61% higher, 95% CI: 1.56, 3.66 for a 10-mmHg increase), age (1.11% higher, 95% CI: 0.92, 1.31 for a 1-year increase), and DM (4.06% higher, 95% CI: 0.84, 7.28 for DM vs. no DM). Ever versus never smoking was positively but not significantly associated with maximum and mean CIMT at LCCA (1.60% higher; 95% CI: --1.90, 5.10 and 1.38% higher; 95% CI: --2.04, 4.80), respectively. Associations between model covariates and RCCA were consistent with those for LCCA (data not shown). One example of such findings for PM~2.5~abs and NO~2~ is presented in Supplemental Material, Table S2. The associations of PM~2.5~abs, PM~10~, NO~2~, and NO~x~ with CIMT became insignificant in two-pollutant models.

###### 

Multivariate linear regression analyses for percent difference (95% CI) in maximum and mean CIMT at LCCA and RCCA and for both combined (CCA) in association with air pollution exposures.

  Exposure (exposure increment)                                                                                                                                                 CIMT at LCCA            CIMT at RCCA            Combined CIMT
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------- ----------------------- -----------------------
  Maximum CIMT                                                                                                                                                                                                                  
  PM~2.5~abs (10^--5^/m)                                                                                                                                                        4.23 (0.32, 8.13)\*     1.63 (--1.98, 5.23)     2.94 (--0.25, 6.14)
  PM~2.5~ (5 μg/m^3^)                                                                                                                                                           --0.28 (--1.68, 1.12)   --0.30 (--1.00, 1.58)   0.001 (--1.15, 1.15)
  PM~10~ (10 μg/m^3^)                                                                                                                                                           3.72 (0.32, 7.11)\*     1.59 (--1.54, 4.72)     2.66 (--0.11, 5.44)
  NO~2~ (20 μg/m^3^)                                                                                                                                                            2.81 (0.32, 5.31)\*     1.79 (--0.52, 4.09)     2.31 (0.26, 4.35)\*
  NO~x~ (10 μg/m^3^)                                                                                                                                                            0.74 (0.08, 1.41)\*     0.29 (--0.32, 0.90)     0.52 (--0.02, 1.06)
  Mean CIMT                                                                                                                                                                                                                     
  PM~2.5~abs (10^--5^/m)                                                                                                                                                        4.19 (0.38, 8.00)\*     0.61 (--2.41, 5.11)     2.78 (--0.50, 6.07)
  PM~2.5~ (5 μg/m^3^)                                                                                                                                                           --0.27 (--1.64, 1.10)   0.16 (--1.19, 1.51)     --0.05 (--1.23, 1.12)
  PM~10~ (10 μg/m^3^)                                                                                                                                                           3.58 (0.27, 6.89)\*     1.76 (--1.51, 5.02)     2.68 (0.17, 5.53)\*
  NO~2~ (20 μg/m^3^)                                                                                                                                                            1.98 (--0.46, 4.42)     1.63 (--0.77, 4.03)     1.81 (--0.30, 3.91)
  NO~x~ (10 μg/m^3^)                                                                                                                                                            0.51 (--0.14, 1.16)     0.16 (--0.48, 0.80)     0.34 (--0.22, 0.90)
  Adjusted for age, sex, BMI, SBP, LDL-C, lipid-lowering treatment (yes/no), DM (yes/no), education (\< or ≥ 12 years), and ever versus never smoking history. \**p* \< 0.05.                                                   

We applied a stratification approach to test differences in subgroups and added interaction terms in our models to test for interactions between air pollutants and key cardiovascular risk factors. The results of effect modification by subgroup analysis showed positive associations between 1-year PM~2.5~abs air pollution exposure and CIMT at LCCA among female and subjects without hypercholesterolemia, never smokers, and non-obese (see Supplemental Material, Table S3). We also found positive associations between 1-year NO~2~ exposure and CIMT at LCCA among female participants and subjects without hypertension or hypercholesterolemia. In addition, subjects with age ≥ 50 years, non-obese or without DM also were sensitive groups (see Supplemental Material, Table S4).

We performed the sensitivity analyses with models by including the eight interaction terms (age, sex, hypertension, BMI, hypercholesterolemia, DM, smoking, and lipid-lowering treatment) one by one, respectively. However, the main air pollution effects remained stable in the analyses for seven of the eight covariates except age in our models. Aged subjects have a positive correlation coefficient of interaction with NO~2~ levels (NO~2~ × age) for CIMT of LCCA (see Supplemental Material, Tables S3 and S4).

Discussion
==========

This study demonstrates the positive association between long-term air pollution exposure, particularly PM (PM~2.5~abs and PM~10~), NO~2~, and NO~x~, and subclinical atherosclerosis in terms of CIMT among adults 35--65 years of age in the Taipei metropolis. The strength of the study was that it yielded consistent findings for the associations between four of five monitored air pollutants and maximum CIMT at LCCA after controlling for other major cardiovascular risk factors.

There are several limitations in this study. We cannot rule out that the results might be overestimated or underestimated. The reliance on volunteers is a major limitation in this study, which may limit the generalization of the study findings. Using the present contrasts in pollution instead of the true ones from the past, associations can potentially be inflated. According to the annual report of Taiwan Environmental Protection Administration (TEPA), air pollution levels in Taipei showed relatively stable PM~10~ concentrations but gradually decreasing NO~2~ levels during 1997--2009 ([@r33]). The lack of data on time--activity for each individual may have led to some misclassification of the amount of exposure during working hours and during other activities undertaken outside of the home ([@r16]). Current LUR models may not represent true exposure for subjects living in high-rise housing in our study, which should be addressed by additional spatial modeling in future studies. Another limitation of the study is the lack of consideration of other risk factors, such as genetic and other environmental factors that might predispose individuals to atherosclerosis ([@r3]; [@r15]; [@r22]). The use of education data only as an indicator for socioeconomic status (SES) may not fully control for the effect of SES on CIMT. There can be a high correlation among places, income, and CIMT in Taipei, which needs to be explored by better measures/proxy of SES in future studies.

This investigation reconfirms the findings of previous studies in the United States and Europe; long-term exposure to PM~10~ and/or PM~2.5~ air pollution is associated with CIMT ([@r1]; [@r7]; [@r18]; [@r21]). Recent prospective studies also have demonstrated this association ([@r1]; [@r4]; [@r17]; [@r34]). Long-term exposures to NO~2~ and NO~x~ were associated with significantly higher maximum CIMT at LCCA, which supports a role of traffic-related gaseous air pollution. Furthermore, PM~2.5~abs, but not PM~2.5~ mass concentration, was associated with subclinical atherosclerosis in our ethnic Chinese population. And, this is the first study to use the LUR models developed by ESCAPE to estimate residential long-term average air pollution levels and successfully link them to individual CIMT in Asia. All of the LUR models for PM~2.5~, PM~2.5~abs, PM~10~, NO~2~, and NO~x~ had high leave-one-out cross-validation *R*^2^ (0.63--0.92), suggesting that the LUR models used for exposure estimation explained the variance of these pollutants in the study area.

The size of the smoking effect on CIMT, though not significant, is comparable with our previous community-based study in Taipei, which did not include air pollution effects ([@r30]). However, we cannot infer that smoking contributes less to subclinical atherosclerosis than does air pollution. First, ever smoking including those currently smoking or ever have smoked who quit for many years may underestimate the atherogenic effects coming from current smoking. Second, we did not quantify the pack-years, which may underestimate the significant effects coming from heavy smokers with ≥ 10 pack-years. Third, the estimated 1-year air pollution concentrations in Taipei area were significantly higher than those measured in most areas in the United States and the European Union; thus the relatively higher contribution of air pollution on CIMT might attenuate the partly similar pathogenic effects from ever smoking observed in this study.

The subgroups that are otherwise at low risk of CVD might be more susceptible to PM~2.5~abs and NO~2~ air pollution exposure; however, the association with NO~2~ exposure was stronger among those ≥ 50 years of age compared with younger participants. As for the modification effect of PM~2.5~abs, the size of point estimate for those taking lipid-lowering treatment was larger than for those who were not. However, the sensitivity analyses revealed no significant interaction effect on the risk for CIMT among these seven major CVD risk factors and air pollutants respectively. Our findings are partly in agreement with the results of [@r18], who found that those on statins treatment, aged, women, and nonsmokers were more susceptible to air pollution. However, our study showed the association among those taking lipid-lowering treatment was stronger for PM~2.5~abs but weaker for NO~2~; the interactions were not significant in either case, and our study population had small numbers on treatment. Our subgroup analysis also was not consistent with findings in the Heinz Nixdorf Recall (HNR) study, which identified the association was slightly stronger in younger and obese subjects ([@r1]). Associations with hypercholesterolemia may be attenuated by adjustment for treatment with lipid-lowering medications. Because of the limited precision of the estimates, we must interpret these subgroup effects with caution.

The atherosclerotic process accelerates generally on both sides in the presence of traditional risk factors such as hypercholesterolemia, DM, higher BP, male sex, and older age. Our results also underscore the importance of measuring both the left and right CCAs for assessing the association with air pollution exposure. We found a stronger association between the four pollutants and maximum LCCA compared with maximum RCCA, but only two pollutants had a stronger association with mean LCCA compared with mean RCCA. It would be reasonable to suggest briefly that there may be a physiologic basis, but there is very little prior evidence to support this. We need further study to confirm it.

The fact that the black carbon content of PM~2.5~abs has a similar association with CIMT compared to that of PM~10~ mass, as demonstrated here, supports the potential importance of composition or components of PM~2.5~ in cardiovascular health ([@r36]). The main sources of black carbon are combustion engines, particularly diesel engines in the Taipei metropolis. An assessment of the health risks and the establishment of regulations for PM~2.5~abs are warranted.

The mechanisms linking air pollution and CVD are proposed in the scientific statement from the American Heart Association by [@r5], and our previous studies may add support for these mechanisms ([@r8]; [@r11]; [@r35], [@r36]). Seasonal variation in PM~10~ levels predicted seasonal variations in plasma fibrinogen levels in a panel study of middle-aged adults ([@r32]). In addition, this study provides supporting evidence of an increased risk of atherosclerosis following long-term air pollution exposure in Asia.

Further investigation is necessary to assess the atherogenic effects of the high concentrations of air pollutants in Taipei, such as the estimated average levels of PM~2.5~, PM~10~, and NO~2~, which are twice to three times those observed in the United States and Europe. Because the urban areas that suffer most from air pollution in the world are located in Asian countries such as China and India ([@r29]), the emerging data regarding adverse cardiovascular effects in Taiwan should be urgently considered by Asian countries. For the proactive prevention of air pollution-related CVD, the catastrophic episode of smog in Beijing, China, in January--February 2013 shows that action must be taken as soon as possible ([@r25]).

In conclusion, long-term exposure to traffic-related air pollution with PM~2.5~abs, PM~10~, NO~2~, and NO~x~ was positively associated with subclinical atherosclerosis, represented by maximal CIMT in middle-aged adults. But the associations were not evident for right CIMT, and PM~2.5~ mass concentration was not associated with the outcomes.

Supplemental Material
=====================

###### 

Click here for additional data file.
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